PGLS-DT
gene geneOn this page
Summary
PGLS-DT (PGLS divergent transcript, HGNC:55274) is a long non-coding RNA gene on chromosome 19p13.11.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:55274 |
| Approved symbol | PGLS-DT |
| Name | PGLS divergent transcript |
| Location | 19p13.11 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000269439 |
| Ensembl biotype | lncRNA |
| Entrez | 100507551 |
| RNAcentral | URS00004AAEAB — lncRNA, 775 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 lncRNA
ENST00000595116, ENST00000596643, ENST00000598141, ENST00000615939, ENST00000655024, ENST00000799627, ENST00000799628
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000595116 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004188339 | 17503416 | 17503622 |
| ENSE00004188342 | 17511343 | 17511562 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 91.70.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.2804 / max 87.8434, expressed in 1504 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179873 | 2.3673 | 1261 |
| 179875 | 0.7287 | 376 |
| 179874 | 0.1845 | 69 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 91.70 | gold quality |
| apex of heart | UBERON:0002098 | 84.45 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 82.68 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 82.31 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.92 | gold quality |
| muscle tissue | UBERON:0002385 | 80.93 | gold quality |
| tibial nerve | UBERON:0001323 | 80.85 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 80.78 | gold quality |
| cerebellum | UBERON:0002037 | 80.76 | gold quality |
| cerebellar cortex | UBERON:0002129 | 80.70 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 80.28 | gold quality |
| left ovary | UBERON:0002119 | 80.18 | gold quality |
| right ovary | UBERON:0002118 | 80.17 | gold quality |
| monocyte | CL:0000576 | 80.09 | gold quality |
| Ammon’s horn | UBERON:0001954 | 80.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 79.94 | gold quality |
| substantia nigra | UBERON:0002038 | 79.77 | gold quality |
| ovary | UBERON:0000992 | 79.76 | gold quality |
| corpus callosum | UBERON:0002336 | 79.73 | gold quality |
| leukocyte | CL:0000738 | 79.53 | gold quality |
| endocervix | UBERON:0000458 | 78.92 | gold quality |
| muscle of leg | UBERON:0001383 | 78.73 | gold quality |
| primary visual cortex | UBERON:0002436 | 78.61 | gold quality |
| colonic epithelium | UBERON:0000397 | 78.44 | gold quality |
| gastrocnemius | UBERON:0001388 | 78.32 | gold quality |
| temporal lobe | UBERON:0001871 | 78.21 | gold quality |
| amygdala | UBERON:0001876 | 78.20 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 77.85 | gold quality |
| putamen | UBERON:0001874 | 77.70 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 77.67 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9543 | yes | 33.42 |
| E-ANND-3 | yes | 3.02 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.